Insider Shareholders with Direct Ownership of Arcturus Therapeutics Holdings Inc. (ARCT)
This section provides a comprehensive overview of the insiders with direct ownership of Arcturus Therapeutics Holdings Inc. (ARCT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Arcturus Therapeutics Holdings Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Joseph E Payne
President and CEO |
5,000 | 0 | 1,480,097 $26.6 Million | 1 |
Nov 23, 2022
Added 0.34%
|
|
Ultragenyx Pharmaceutical Inc.
Director |
0 | 1,600,000 | 1,400,000 $25.2 Million | 4 |
Aug 11, 2021
Reduced 5.08%
|
|
Pad Chivukula
Chief Scientific Officer & COO |
0 | 287,214 | 435,334 $7.84 Million | 31 |
Oct 15, 2024
Reduced 2.68%
|
|
Andy Sassine
Chief Financial Officer |
2,291 | 50,000 | 220,526 $3.97 Million | 3 |
Jun 12, 2024
Reduced 18.48%
|
|
Peter C Farrell
Director |
3,131 | 0 | 55,741 $1 Million | 1 |
Jun 14, 2024
Added 5.32%
|
|
James F Barlow
Director |
3,131 | 0 | 13,131 $236,358 | 1 |
Jun 14, 2024
Added 19.25%
|
|
Magda Marquet
Director |
3,131 | 0 | 3,131 $56,358 | 1 |
Jun 14, 2024
Added 50.0%
|
|
Jing L. Marantz
Director |
3,131 | 0 | 3,131 $56,358 | 1 |
Jun 14, 2024
Added 50.0%
|
|
John Markels
Director |
3,131 | 0 | 3,131 $56,358 | 1 |
Jun 14, 2024
Added 50.0%
|
|
Edward W Holmes
Director |
3,131 | 0 | 3,131 $56,358 | 1 |
Jun 14, 2024
Added 50.0%
|
|
Keith C Kummerfeld
Officer |
13,936 | 13,936 | 950 $17,100 | 4 |
Jul 14, 2023
Reduced 88.0%
|